Adjuvant Pancreatic Therapy Guided by MRD

Clinical trial NCT06966440 · RECRUITING

Trial details

NCT number: NCT06966440
Sponsor: Ruijin Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Pancreatic Adenocarcinoma Resectable

Start date: 2025-06-01
Primary completion: 2028-06-01
Enrollment: 856

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.